Harvard Bioscience, Inc.HBIONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-11.54%
↓ 200% below average
Average (9y)
11.58%
Historical baseline
Range
High:94.65%
Low:-18.95%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -11.54% |
| 2023 | -4.58% |
| 2022 | 14.17% |
| 2021 | 24.34% |
| 2020 | -18.95% |
| 2019 | -2.48% |
| 2018 | 94.65% |
| 2017 | 4.69% |
| 2016 | -16.01% |
| 2015 | 31.56% |